We are live on ! Find out more
MG

Meditor Group Portfolio holdings

AUM $48.1M
1-Year Est. Return 38.67%
This Fund
S&P 500
This Quarter Est. Return
+37.54%
1 Year Est. Return
+38.67%
3 Year Est. Return
+41.15%
5 Year Est. Return
+72.2%
10 Year Est. Return
+1,065.64%
AUM
$80M
AUM Growth
+$2.87M
Cap. Flow
-$10.9M
Cap. Flow %
-13.58%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
EXEL icon
Exelixis
EXEL
+$10.9M

Sector Composition

Rank Sector Weight
1 Healthcare 93.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXEL icon
1
Exelixis
EXEL
$13.9B
$63.3M 79.1%
2,638,300
-499,900
-16% -$10.9M
ESPR
2
DELISTED
Esperion Therapeutics
ESPR
$11.3M 14.17%
3,791,300
– –
INDA icon
3
iShares MSCI India ETF
INDA
$6.71B
$2.9M 3.62%
59,400
– –
EPI icon
4
WisdomTree India Earnings Fund ETF
EPI
$2.02B
$2.49M 3.11%
60,700
– –

Similar funds

BHCM
Boulder Hill Capital Management New York $47.9M AUM
VMV
Venrock Management VI Palo Alto, California $47.6M AUM 45.26% 1-Year Est. Return
BHH
Baker Hughes Holdings Houston, Texas $47.6M AUM 26.35% 1-Year Est. Return
LAMC
Lubert-Adler Management Company Philadelphia, Pennsylvania $49.3M AUM 17.46% 1-Year Est. Return
MAM
Miria Asset Management St. Julians, Malta $49.9M AUM 21.84% 1-Year Est. Return
BCM
BlueMar Capital Management Miami, Florida $49.9M AUM 28.76% 1-Year Est. Return
LOF
Lightspeed Opportunity Fund Menlo Park, California $50.1M AUM 53.1% 1-Year Est. Return
CLCM
Center Lake Capital Management West Palm Beach, Florida $45.8M AUM 58.23% 1-Year Est. Return

Meditor Group's Q4 2023 Portfolio in Review

As of Q4 2023, Meditor Group held 4 positions worth $80M, up 3.7% from $77.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Meditor Group withdrew a net $10.9M in Q4 2023, reducing 1 holding. Its largest reduction was Exelixis, cutting an estimated $10.9M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, down from 94% a quarter earlier.

  • Meditor Group's biggest Q4 2023 reduction was Exelixis, cutting an estimated $10.9M.
  • Meditor Group's ten largest holdings make up 100% of its $80M portfolio in Q4 2023.
  • Meditor Group opened 0 new positions and closed 0 in Q4 2023.
  • Meditor Group's portfolio value rose 3.7% quarter-over-quarter to $80M.

Based on Meditor Group's 13F filing for Q4 2023, filed 4 Jan 2024.